Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Mindray Medical International Limited ADR r ( MR) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 1.8%. By the end of trading, Mindray Medical International Limited ADR r rose $0.47 (1.4%) to $33.22 on average volume. Throughout the day, 875,712 shares of Mindray Medical International Limited ADR r exchanged hands as compared to its average daily volume of 909,400 shares. The stock ranged in a price between $32.64-$33.66 after having opened the day at $32.78 as compared to the previous trading day's close of $32.75. Other companies within the Health Services industry that increased today were: RadNet ( RDNT), up 8.4%, IsoRay ( ISR), up 4.3%, Select Medical Holdings Corporation ( SEM), up 4.3% and Dynatronics Corporation ( DYNT), up 2.9%.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International Limited ADR r has a market cap of $3.9 billion and is part of the health care sector. Shares are down 10.0% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Mindray Medical International Limited ADR r a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates Mindray Medical International Limited ADR r as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Spherix ( SPEX), down 12.1%, Psychemedics Corporation ( PMD), down 8.9%, Rosetta Genomics ( ROSG), down 8.2% and EnteroMedics ( ETRM), down 7.8% , were all laggards within the health services industry with Abbott Laboratories ( ABT) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.